Armistice Capital, LLC Sol Gel Technologies Ltd. Call Options Transaction History
Armistice Capital, LLC
- $7.34 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SLGL
# of Institutions
23Shares Held
7.75MCall Options Held
200Put Options Held
300-
Phoenix Holdings Ltd. Givatayim, L32.57MShares$2.11 Million0.04% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.1.23MShares$1.01 Million0.02% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.920KShares$754,6730.02% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY482KShares$395,0340.06% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3229KShares$187,9250.05% of portfolio
About Sol-Gel Technologies Ltd.
- Ticker SLGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,129,500
- Market Cap $19M
- Description
- Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...